Eeva Piitulainen

4.7k total citations · 1 hit paper
85 papers, 3.1k citations indexed

About

Eeva Piitulainen is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Physiology. According to data from OpenAlex, Eeva Piitulainen has authored 85 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Pulmonary and Respiratory Medicine, 29 papers in Cancer Research and 19 papers in Physiology. Recurrent topics in Eeva Piitulainen's work include Chronic Obstructive Pulmonary Disease (COPD) Research (42 papers), Protease and Inhibitor Mechanisms (29 papers) and Pulmonary Hypertension Research and Treatments (15 papers). Eeva Piitulainen is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (42 papers), Protease and Inhibitor Mechanisms (29 papers) and Pulmonary Hypertension Research and Treatments (15 papers). Eeva Piitulainen collaborates with scholars based in Sweden, Denmark and United States. Eeva Piitulainen's co-authors include Robert A. Stockley, Hanan Tanash, Asger Dirksen, Sten Eriksson, David Parr, Berend C. Stoel, Tomas Sveger, Jan Stolk, Noel G. McElvaney and C. Q. Deng and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Eeva Piitulainen

82 papers receiving 3.1k citations

Hit Papers

Intravenous augmentation treatment and lung density in se... 2015 2026 2018 2022 2015 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial
    2015 325 citations Kenneth R. Chapman, Jonathan Burdon et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eeva Piitulainen Sweden 32 1.7k 1.3k 999 537 518 85 3.1k
Niels Seersholm Denmark 27 2.1k 1.2× 862 0.7× 869 0.9× 423 0.8× 297 0.6× 70 3.4k
David Parr United Kingdom 18 1.3k 0.7× 580 0.5× 441 0.4× 326 0.6× 189 0.4× 50 1.8k
Kazuo Kasahara Japan 32 2.5k 1.4× 676 0.5× 1.7k 1.7× 546 1.0× 42 0.1× 255 3.7k
Toshihiko Iizasa Japan 42 3.3k 1.9× 608 0.5× 2.4k 2.4× 249 0.5× 93 0.2× 146 6.3k
Seongsoo Jang South Korea 29 417 0.2× 159 0.1× 725 0.7× 275 0.5× 1.2k 2.3× 236 3.3k
Catherine K. Chow United States 24 492 0.3× 361 0.3× 1.0k 1.0× 95 0.2× 316 0.6× 40 2.6k
John P. Perentesis United States 39 1.3k 0.7× 322 0.3× 636 0.6× 80 0.1× 764 1.5× 140 4.1k
James A. Waldron United States 32 2.9k 1.7× 78 0.1× 805 0.8× 1.0k 1.9× 400 0.8× 61 4.9k
Diana N. Ionescu Canada 26 1.1k 0.7× 466 0.4× 893 0.9× 235 0.4× 30 0.1× 78 2.7k
Sara Pilotto Italy 29 1.1k 0.6× 485 0.4× 1.8k 1.8× 197 0.4× 40 0.1× 187 2.9k

Countries citing papers authored by Eeva Piitulainen

Since Specialization
Citations

This map shows the geographic impact of Eeva Piitulainen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eeva Piitulainen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eeva Piitulainen more than expected).

Fields of papers citing papers by Eeva Piitulainen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eeva Piitulainen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eeva Piitulainen. The network helps show where Eeva Piitulainen may publish in the future.

Co-authorship network of co-authors of Eeva Piitulainen

This figure shows the co-authorship network connecting the top 25 collaborators of Eeva Piitulainen. A scholar is included among the top collaborators of Eeva Piitulainen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eeva Piitulainen. Eeva Piitulainen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanash, Hanan, et al.. (2024). COVID-19 in Individuals with Severe Alpha 1-Antitrypsin Deficiency. International Journal of COPD. Volume 19. 2661–2669.
2.
Piitulainen, Eeva, et al.. (2022). The Clinical Course of Severe Alpha-1-Antitrypsin Deficiency in Patients Identified by Screening. SHILAP Revista de lepidopterología. 1 indexed citations
3.
Truedsson, Mikael, et al.. (2020). Kardiellt troponin – en biomarkör för hjärt–kärlsjukdom vid KOL. Läkartidningen. 117. 1–5. 1 indexed citations
4.
Piitulainen, Eeva, et al.. (2019). Decline in FEV1 and hospitalized exacerbations in individuals with severe alpha-1 antitrypsin deficiency. SHILAP Revista de lepidopterología. 1 indexed citations
5.
Lundblad, Lennart K. A., et al.. (2019). Oscillometry in Chronic Obstructive Lung Disease: In vitro and in vivo evaluation of the impulse oscillometry and tremoflo devices. Scientific Reports. 9(1). 11618–11618. 19 indexed citations
6.
Torén, Kjell, Anna-Carin Olin, Anne Lindberg, et al.. (2016). Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS). International Journal of COPD. 11. 927–927. 31 indexed citations
7.
Tanash, Hanan, et al.. (2015). The Swedish α1-Antitrypsin Screening Study: Health Status and Lung and Liver Function at Age 34. Annals of the American Thoracic Society. 12(6). 807–812. 19 indexed citations
8.
Chapman, Kenneth R., Jonathan Burdon, Eeva Piitulainen, et al.. (2015). Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial. The Lancet. 386(9991). 360–368. 325 indexed citations breakdown →
9.
Sandhaus, Robert A., Kenneth R. Chapman, Jonathan Burdon, et al.. (2014). Integrated safety across six clinical trials of alpha-1 augmentation therapy. European Respiratory Journal. 44(Suppl 58). P950–P950. 2 indexed citations
10.
Stocks, James, Robert A. Sandhaus, Kenneth R. Chapman, et al.. (2014). Baseline Patient Demographics and Lung Density Decline in the RAPID Trial. CHEST Journal. 146(4). 71A–71A. 1 indexed citations
11.
Díaz, Sandra, et al.. (2010). CT lung densitometry in young adults with alpha-1-antitrypsin deficiency. Respiratory Medicine. 105(1). 74–79. 8 indexed citations
12.
Díaz, Sandra, Eeva Piitulainen, Peter Magnusson, et al.. (2009). Progression of Emphysema in a 12-month Hyperpolarized 3He-MRI Study. Academic Radiology. 16(6). 700–707. 21 indexed citations
13.
Wollmer, Per, et al.. (2009). Lung function in 30-year-old alpha-1-antitrypsin-deficient individuals. Respiratory Medicine. 103(6). 861–865. 15 indexed citations
14.
Dirksen, Asger, Eeva Piitulainen, David Parr, et al.. (2009). Exploring the role of CT densitometry: a randomised study of augmentation therapy in α1-antitrypsin deficiency. European Respiratory Journal. 33(6). 1345–1353. 250 indexed citations
15.
Bakker, Margreet, Hein Putter, Jan Stolk, et al.. (2008). Assessment of Regional Progression of Pulmonary Emphysema With CT Densitometry. CHEST Journal. 134(5). 931–937. 20 indexed citations
16.
Tanash, Hanan, et al.. (2008). Clinical course and prognosis of never-smokers with severe alpha-1-antitrypsin deficiency (PiZZ). Thorax. 63(12). 1091–1095. 64 indexed citations
17.
Stockley, Robert A., et al.. (2007). Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development. European Respiratory Journal. 29(3). 582–586. 61 indexed citations
18.
Piitulainen, Eeva, et al.. (2002). Nutritional Status and Muscle Strength in Patients with Emphysema and Severe α1-Antitrypsin Deficiency. CHEST Journal. 122(4). 1240–1246. 21 indexed citations
19.
Piitulainen, Eeva, Göran Tornling, & Sten Eriksson. (1998). Environmental correlates of impaired lung function in non-smokers with severe alpha 1-antitrypsin deficiency (PiZZ). Thorax. 53(11). 939–943. 42 indexed citations
20.
Sveger, Tomas, Eeva Piitulainen, & M Arborelius. (1995). Clinical features and lung function in 18‐year‐old adolescents with α1‐antitrypsin deficiency. Acta Paediatrica. 84(7). 815–816. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Niels Seersholm Breakdown of academic impact, for papers by David Parr Breakdown of academic impact, for papers by Kazuo Kasahara Breakdown of academic impact, for papers by Toshihiko Iizasa Breakdown of academic impact, for papers by Seongsoo Jang Breakdown of academic impact, for papers by Catherine K. Chow Breakdown of academic impact, for papers by John P. Perentesis Breakdown of academic impact, for papers by James A. Waldron Breakdown of academic impact, for papers by Diana N. Ionescu Breakdown of academic impact, for papers by Sara Pilotto
Rankless by CCL
2026